SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-034176
Filing Date
2023-10-10
Accepted
2023-10-10 16:49:56
Documents
15
Period of Report
2023-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K frtx-20231003.htm   iXBRL 8-K 30828
2 EX-10.1 a202310038kex101.htm EX-10.1 112321
3 EX-10.2 a202310038kex102.htm EX-10.2 84426
7 frtx-20231003_g1.jpg GRAPHIC 29102
  Complete submission text file 0001628280-23-034176.txt   466028

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20231003.xsd EX-101.SCH 1905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20231003_lab.xml EX-101.LAB 25156
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20231003_pre.xml EX-101.PRE 13052
9 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20231003_htm.xml XML 2826
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 231318499
SIC: 2836 Biological Products, (No Diagnostic Substances)